Cancer Control (Dec 2020)

Prognostic Significance of Lactate Dehydrogenase in Patients Undergoing Surgical Resection for Laryngeal Squamous Cell Carcinoma

  • Erliang Guo MD,
  • Lunhua Guo MD,
  • Changming An MD,
  • Cong Zhang MD,
  • Kaibin Song MD,
  • Guohui Wang MD,
  • Chunbin Duan MD,
  • Xiwei Zhang MD,
  • Xianguang Yang MD,
  • Zhennan Yuan MD,
  • Junnan Guo MD,
  • Ji Sun MD,
  • Hongxue Meng MD,
  • Rui Chang MD,
  • Xiaomei Li MD,
  • Cheng Xiu MD,
  • Xionghui Mao MD,
  • Susheng Miao MD

DOI
https://doi.org/10.1177/1073274820978795
Journal volume & issue
Vol. 27

Abstract

Read online

The aim is to estimate the prognostic value of lactate dehydrogenase (LDH) in patients undergoing surgical resection for laryngeal squamous cell carcinoma (LSCC). A total of 640 resected LSCC patients were included. Preoperative lactate dehydrogenase (LDH) was assessed. Kaplan-Meier survival analysis and Cox regression analysis were conducted for overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier analysis, univariate analysis and multivariate analysis demonstrated significant prognostic value for preoperative LDH. Although LDH was predictor of OS, it failed to be a predictor of RFS. The univariate HR and 95% CI of LDH were 0.484 and 0.357-0.658 (P 132 IU/L was significantly associated with better survival. Preoperative LDH might be an independent prognostic marker of OS in LSCC patients undergoing surgical resection.